G47.31
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Body mass index below 35 kg/m² • Obstructive sleep apnoea .. • diagnosed for the first time at T1 at the Sleep Medicine Centre of the Otorhinolaryngology Department of the Mainz University Medical Centre .. • still untreated at T1 • Consent into an auto-titrating ventilation as part of the routine therapy • Written informed consent into study participation including .. • three interviews of 10 minutes each (see “Primary Outcome”) .. • pseudonymised data electronic storage and validation of personal data
Exclusion criteria
Exclusion criteria: • Actual known pregnancy, known cardiac insufficiency, chronic obstructive pulmonary disease stadium III or higher according to GOLD, psychiatric, neurologic or neurodegenerative diseases, narcolepsy or restless-legs syndrome • Status after apoplexy, myocardial infarction or malign neoplasm • Further disease that influence the apnoea-hypopnoea-index (predictor) and the sleepiness during the day • Neuroleptics, antiepileptic drugs, antidepressants, sedatives and further substances that influence the apnoea-hypopnoea-index (predictor) and the sleepiness during the day
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective appraisal at T1, T2, and T3 of the impairment caused by the obstructive sleep apnea; the four categories are "irrelevant", "mild", "middle", and "severe". | — |
Secondary
| Measure | Time frame |
|---|---|
| Berlin Snoring Questionnaire, Insomnia Severity Index, Epworth Sleepiness Scale | — |
Countries
Germany
Contacts
medscoops - Health Sciences